![Karin Ilg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karin Ilg
Keine laufenden Positionen mehr
Karriereverlauf von Karin Ilg
Ehemalige bekannte Positionen von Karin Ilg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Malcisbo AG
![]() Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 | - |
Ausbildung von Karin Ilg
University of Regensburg | Undergraduate Degree |
Statistik
International
Schweiz | 2 |
Deutschland | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Malcisbo AG
![]() Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |